Literature DB >> 6833536

Regression in malignant melanoma.

H Trau, A W Kopf, D S Rigel, J Levine, G Rogers, M Levenstein, R S Bart, M M Mintzis, R J Friedman.   

Abstract

A multiple stepwise logistic regression analysis shows that histologic regression is more likely to be found in a malignant melanoma that is level III or less, more than 10 mm in diameter, associated with solar elastosis, located on an anatomic area other than the head or neck, and when there are areas of whiteness clinically. Although patients with malignant melanomas displaying signs of regression histologically have a slightly better 5-year disease-free survival, this may be attributed to a difference in tumor thickness.

Entities:  

Mesh:

Year:  1983        PMID: 6833536     DOI: 10.1016/s0190-9622(83)70040-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  Gastrointestinal bleeding as the first manifestation of a burned-out tumour of the testis.

Authors:  Cecilia Castillo; Gabriel Krygier; Julio Carzoglio; Raúl Cepellini Magariños; Raúl Cepellini Olmos; Juan Jubín; Graciela Sabini
Journal:  Clin Transl Oncol       Date:  2005-11       Impact factor: 3.405

2.  Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.

Authors:  Phyu P Aung; Priyadharsini Nagarajan; Victor G Prieto
Journal:  Lab Invest       Date:  2017-02-27       Impact factor: 5.662

Review 3.  [Role of MHC class I molecules in anti-tumoral mechanisms in human malignant melanoma].

Authors:  J Dissemond; S Grabbe
Journal:  Hautarzt       Date:  2006-08       Impact factor: 0.751

4.  Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.

Authors:  J W Kelly; R W Sagebiel; S Clyman; M S Blois
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

5.  Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.

Authors:  H J Wanebo; P H Cooper; R W Hagar
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

6.  Clinical features of superficial spreading melanomas with zones of regression.

Authors:  B M Czarnetzki; M Denter; E B Bröcker; P Rümke; V Krieg; F Vakilzadeh; E Macher
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

7.  Significance of Primary Melanoma Regression on Local Infiltrate and Outcome.

Authors:  Awatef Kelati; Brigitte Balme; Brigitte Chouvet; Alexandra Traverse-Glehen; Juliette Tantot; Olivier Harou; Gérard Duru; Sebastien Debarbieux; Stephane Dalle; Luc Thomas
Journal:  Dermatol Pract Concept       Date:  2022-01-01

8.  Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors.

Authors:  Sabina Zurac; Monica Neagu; Carolina Constantin; Mirela Cioplea; Roxana Nedelcu; Alexandra Bastian; Cristiana Popp; Luciana Nichita; Razvan Andrei; Tiberiu Tebeica; Cristiana Tanase; Virginia Chitu; Constantin Caruntu; Mihaela Ghita; Catalin Popescu; Daniel Boda; Bogdan Mastalier; Nicoleta Maru; Claudiu Daha; Bogdan Andreescu; Ioan Marinescu; Adrian Rebosapca; Florica Staniceanu; Gabriela Negroiu; Daniela A Ion; Dragana Nikitovic; George N Tzanakakis; Demetrios A Spandidos; Aristidis M Tsatsakis
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.